Effects of Exogenous Glucagon-Like Peptide-1 on the Blood Pressure, Heart Rate, Mesenteric Blood Flow, and Glycemic Responses to Intraduodenal Glucose in Healthy Older Subjects

Context:Studies relating to the cardiovascular effects of glucagon-like peptide-1 (GLP-1) and its agonists, which slow gastric emptying, have not discriminated between fasting and postprandial, blood pressure (BP) and heart rate (HR).Objective:To determine whether exogenous GLP-1 modulates the effec...

Full description

Saved in:
Bibliographic Details
Published inThe journal of clinical endocrinology and metabolism Vol. 99; no. 12; pp. E2628 - E2634
Main Authors Trahair, Laurence G., Horowitz, Michael, Hausken, Trygve, Feinle-Bisset, Christine, Rayner, Christopher K., Jones, Karen L.
Format Journal Article
LanguageEnglish
Published United States Oxford University Press 01.12.2014
Copyright by The Endocrine Society
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Context:Studies relating to the cardiovascular effects of glucagon-like peptide-1 (GLP-1) and its agonists, which slow gastric emptying, have not discriminated between fasting and postprandial, blood pressure (BP) and heart rate (HR).Objective:To determine whether exogenous GLP-1 modulates the effects of an intraduodenal (ID) glucose infusion on BP, HR, and splanchnic blood flow in healthy older subjects.Design:A double-blind randomized trial was conducted.Setting:Community-dwelling residents attended a clinical research laboratory.Patients:Ten healthy “older” subjects (9 male, 1 female; age 73.2 ± 1.5 y) were studied.Interventions:Intravenous infusion of GLP-1 (0.9 pmol/kg/min), or saline (0.9%) for 90 min (t = −30–60 min). Between t = 0–60 min, ID glucose was infused at 3 kcal/min.Main Outcome Measures:BP, HR, superior mesenteric artery (SMA) flow, blood glucose, and serum insulin were measured.Results:During the fasting period (t = −30–0 min), GLP-1 had no effect on BP or HR. In response to ID glucose (t = 0–60 min), systolic BP decreased (P < .001), and both HR (P < .001) and SMA flow (P < .05) increased, on both days. GLP-1 attenuated the maximum decrease in systolic BP (P < .05), tended to increase HR (P = .09), and increased SMA flow (P < .01). GLP-1 diminished the glycemic response (P < .05).Conclusions:In healthy older subjects, acute administration of GLP-1 attenuates the hypotensive response to ID glucose, and potentiates the increase in SMA flow.
AbstractList Studies relating to the cardiovascular effects of glucagon-like peptide-1 (GLP-1) and its agonists, which slow gastric emptying, have not discriminated between fasting and postprandial, blood pressure (BP) and heart rate (HR).CONTEXTStudies relating to the cardiovascular effects of glucagon-like peptide-1 (GLP-1) and its agonists, which slow gastric emptying, have not discriminated between fasting and postprandial, blood pressure (BP) and heart rate (HR).To determine whether exogenous GLP-1 modulates the effects of an intraduodenal (ID) glucose infusion on BP, HR, and splanchnic blood flow in healthy older subjects.OBJECTIVETo determine whether exogenous GLP-1 modulates the effects of an intraduodenal (ID) glucose infusion on BP, HR, and splanchnic blood flow in healthy older subjects.A double-blind randomized trial was conducted.DESIGNA double-blind randomized trial was conducted.Community-dwelling residents attended a clinical research laboratory.SETTINGCommunity-dwelling residents attended a clinical research laboratory.Ten healthy "older" subjects (9 male, 1 female; age 73.2 ± 1.5 y) were studied.PATIENTSTen healthy "older" subjects (9 male, 1 female; age 73.2 ± 1.5 y) were studied.Intravenous infusion of GLP-1 (0.9 pmol/kg/min), or saline (0.9%) for 90 min (t = -30-60 min). Between t = 0-60 min, ID glucose was infused at 3 kcal/min.INTERVENTIONSIntravenous infusion of GLP-1 (0.9 pmol/kg/min), or saline (0.9%) for 90 min (t = -30-60 min). Between t = 0-60 min, ID glucose was infused at 3 kcal/min.BP, HR, superior mesenteric artery (SMA) flow, blood glucose, and serum insulin were measured.MAIN OUTCOME MEASURESBP, HR, superior mesenteric artery (SMA) flow, blood glucose, and serum insulin were measured.During the fasting period (t = -30-0 min), GLP-1 had no effect on BP or HR. In response to ID glucose (t = 0-60 min), systolic BP decreased (P < .001), and both HR (P < .001) and SMA flow (P < .05) increased, on both days. GLP-1 attenuated the maximum decrease in systolic BP (P < .05), tended to increase HR (P = .09), and increased SMA flow (P < .01). GLP-1 diminished the glycemic response (P < .05).RESULTSDuring the fasting period (t = -30-0 min), GLP-1 had no effect on BP or HR. In response to ID glucose (t = 0-60 min), systolic BP decreased (P < .001), and both HR (P < .001) and SMA flow (P < .05) increased, on both days. GLP-1 attenuated the maximum decrease in systolic BP (P < .05), tended to increase HR (P = .09), and increased SMA flow (P < .01). GLP-1 diminished the glycemic response (P < .05).In healthy older subjects, acute administration of GLP-1 attenuates the hypotensive response to ID glucose, and potentiates the increase in SMA flow.CONCLUSIONSIn healthy older subjects, acute administration of GLP-1 attenuates the hypotensive response to ID glucose, and potentiates the increase in SMA flow.
Studies relating to the cardiovascular effects of glucagon-like peptide-1 (GLP-1) and its agonists, which slow gastric emptying, have not discriminated between fasting and postprandial, blood pressure (BP) and heart rate (HR). To determine whether exogenous GLP-1 modulates the effects of an intraduodenal (ID) glucose infusion on BP, HR, and splanchnic blood flow in healthy older subjects. A double-blind randomized trial was conducted. Community-dwelling residents attended a clinical research laboratory. Ten healthy "older" subjects (9 male, 1 female; age 73.2 ± 1.5 y) were studied. Intravenous infusion of GLP-1 (0.9 pmol/kg/min), or saline (0.9%) for 90 min (t = -30-60 min). Between t = 0-60 min, ID glucose was infused at 3 kcal/min. BP, HR, superior mesenteric artery (SMA) flow, blood glucose, and serum insulin were measured. During the fasting period (t = -30-0 min), GLP-1 had no effect on BP or HR. In response to ID glucose (t = 0-60 min), systolic BP decreased (P < .001), and both HR (P < .001) and SMA flow (P < .05) increased, on both days. GLP-1 attenuated the maximum decrease in systolic BP (P < .05), tended to increase HR (P = .09), and increased SMA flow (P < .01). GLP-1 diminished the glycemic response (P < .05). In healthy older subjects, acute administration of GLP-1 attenuates the hypotensive response to ID glucose, and potentiates the increase in SMA flow.
Context:Studies relating to the cardiovascular effects of glucagon-like peptide-1 (GLP-1) and its agonists, which slow gastric emptying, have not discriminated between fasting and postprandial, blood pressure (BP) and heart rate (HR).Objective:To determine whether exogenous GLP-1 modulates the effects of an intraduodenal (ID) glucose infusion on BP, HR, and splanchnic blood flow in healthy older subjects.Design:A double-blind randomized trial was conducted.Setting:Community-dwelling residents attended a clinical research laboratory.Patients:Ten healthy “older” subjects (9 male, 1 female; age 73.2 ± 1.5 y) were studied.Interventions:Intravenous infusion of GLP-1 (0.9 pmol/kg/min), or saline (0.9%) for 90 min (t = −30–60 min). Between t = 0–60 min, ID glucose was infused at 3 kcal/min.Main Outcome Measures:BP, HR, superior mesenteric artery (SMA) flow, blood glucose, and serum insulin were measured.Results:During the fasting period (t = −30–0 min), GLP-1 had no effect on BP or HR. In response to ID glucose (t = 0–60 min), systolic BP decreased (P < .001), and both HR (P < .001) and SMA flow (P < .05) increased, on both days. GLP-1 attenuated the maximum decrease in systolic BP (P < .05), tended to increase HR (P = .09), and increased SMA flow (P < .01). GLP-1 diminished the glycemic response (P < .05).Conclusions:In healthy older subjects, acute administration of GLP-1 attenuates the hypotensive response to ID glucose, and potentiates the increase in SMA flow.
CONTEXT:Studies relating to the cardiovascular effects of glucagon-like peptide-1 (GLP-1) and its agonists, which slow gastric emptying, have not discriminated between fasting and postprandial, blood pressure (BP) and heart rate (HR). OBJECTIVE:To determine whether exogenous GLP-1 modulates the effects of an intraduodenal (ID) glucose infusion on BP, HR, and splanchnic blood flow in healthy older subjects. DESIGN:A double-blind randomized trial was conducted. SETTING:Community-dwelling residents attended a clinical research laboratory. PATIENTS:Ten healthy “older” subjects (9 male, 1 female; age 73.2 ± 1.5 y) were studied. INTERVENTIONS:Intravenous infusion of GLP-1 (0.9 pmol/kg/min), or saline (0.9%) for 90 min (t = −30–60 min). Between t = 0–60 min, ID glucose was infused at 3 kcal/min. MAIN OUTCOME MEASURES:BP, HR, superior mesenteric artery (SMA) flow, blood glucose, and serum insulin were measured. RESULTS:During the fasting period (t = −30–0 min), GLP-1 had no effect on BP or HR. In response to ID glucose (t = 0–60 min), systolic BP decreased (P < .001), and both HR (P < .001) and SMA flow (P < .05) increased, on both days. GLP-1 attenuated the maximum decrease in systolic BP (P < .05), tended to increase HR (P = .09), and increased SMA flow (P < .01). GLP-1 diminished the glycemic response (P < .05). CONCLUSIONS:In healthy older subjects, acute administration of GLP-1 attenuates the hypotensive response to ID glucose, and potentiates the increase in SMA flow.
Author Rayner, Christopher K.
Jones, Karen L.
Horowitz, Michael
Hausken, Trygve
Trahair, Laurence G.
Feinle-Bisset, Christine
AuthorAffiliation Discipline of Medicine (L.G.T., M.H., C.F.-B., C.K.R., K.L.J.), The University of Adelaide, Adelaide 5005, Australia; National Health and Medical Research Council Centre of Research Excellence in Translating Nutritional Science to Good Health (L.G.T., M.H., C.F.-B., C.K.R., K.L.J.), The University of Adelaide, Adelaide 5005, Australia; and Section for Gastroenterology (T.H.), Department of Clinical Medicine, University of Bergen, N-5020 Bergen, Norway
AuthorAffiliation_xml – name: Discipline of Medicine (L.G.T., M.H., C.F.-B., C.K.R., K.L.J.), The University of Adelaide, Adelaide 5005, Australia; National Health and Medical Research Council Centre of Research Excellence in Translating Nutritional Science to Good Health (L.G.T., M.H., C.F.-B., C.K.R., K.L.J.), The University of Adelaide, Adelaide 5005, Australia; and Section for Gastroenterology (T.H.), Department of Clinical Medicine, University of Bergen, N-5020 Bergen, Norway
Author_xml – sequence: 1
  givenname: Laurence G.
  surname: Trahair
  fullname: Trahair, Laurence G.
  organization: 1Discipline of Medicine (L.G.T., M.H., C.F.-B., C.K.R., K.L.J.), The University of Adelaide, Adelaide 5005, Australia
– sequence: 2
  givenname: Michael
  surname: Horowitz
  fullname: Horowitz, Michael
  organization: 1Discipline of Medicine (L.G.T., M.H., C.F.-B., C.K.R., K.L.J.), The University of Adelaide, Adelaide 5005, Australia
– sequence: 3
  givenname: Trygve
  surname: Hausken
  fullname: Hausken, Trygve
  organization: 3Section for Gastroenterology (T.H.), Department of Clinical Medicine, University of Bergen, N-5020 Bergen, Norway
– sequence: 4
  givenname: Christine
  surname: Feinle-Bisset
  fullname: Feinle-Bisset, Christine
  organization: 1Discipline of Medicine (L.G.T., M.H., C.F.-B., C.K.R., K.L.J.), The University of Adelaide, Adelaide 5005, Australia
– sequence: 5
  givenname: Christopher K.
  surname: Rayner
  fullname: Rayner, Christopher K.
  organization: 1Discipline of Medicine (L.G.T., M.H., C.F.-B., C.K.R., K.L.J.), The University of Adelaide, Adelaide 5005, Australia
– sequence: 6
  givenname: Karen L.
  surname: Jones
  fullname: Jones, Karen L.
  email: karen.jones@adelaide.edu.au
  organization: 1Discipline of Medicine (L.G.T., M.H., C.F.-B., C.K.R., K.L.J.), The University of Adelaide, Adelaide 5005, Australia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25210879$$D View this record in MEDLINE/PubMed
BookMark eNp1ks1v2yAYxq2p05p2u-08Ie2wHeKOLxv7uFXph5SpVbdJuyGMXzdOCWSAleW_6p9YnKSXSkVCgPg9D_A-nGRH1lnIso8EnxFK8LelPqOY8JxyUbzJJqTmRS5ILY6yCcaU5LWgf4-zkxCWOGG8YO-yY1okZSXqSfY46zrQMSDXodl_dw_WDQFdmkGre2fzef8A6BbWsW8hJ8hZFBeAfhjnWnTrIYTBwxRdgfIR3amY5j8hgI3ge33ALozbTJGybXLdaliljTsIa2cDBBQdurbRq3ZwLVhldie7AKi3o6uJiy26MS149GtoluNF32dvO2UCfDiMp9mfi9nv86t8fnN5ff59nmteUpaLRgmoRFdUXdPQTou21liVqsWFqKFklSiBdZimKjQa6rorGTCOldCYNYAJO82-7n3X3v0bIES56oMGY5SFVCJJSsapqElVJPTzC3TpBp9eEyQjJeclpkwk6tOBGpoVtHLt-5XyW_mcRQLoHtDeheChk7qPKvZuLFBvJMFyDFwutRwDl2PgSTR9IXr2fQXne3zjTAopPJhhA14udqWWODVeiiofBYSmVZ66YEn2ZS9zw_q1A3YfkD0BlsvHyQ
CitedBy_id crossref_primary_10_1007_s11906_015_0621_6
crossref_primary_10_1186_s12933_016_0490_6
crossref_primary_10_3390_nu13082826
crossref_primary_10_1111_dom_15529
crossref_primary_10_14814_phy2_13073
crossref_primary_10_1111_bcp_12843
crossref_primary_10_3390_nu11112666
crossref_primary_10_2337_db15_0893
crossref_primary_10_1007_s00125_015_3638_0
crossref_primary_10_1186_s12877_019_1251_7
crossref_primary_10_14814_phy2_13102
crossref_primary_10_1210_clinem_dgaa341
crossref_primary_10_2337_db16_0762
crossref_primary_10_1111_dom_13864
crossref_primary_10_1177_1479164116666761
crossref_primary_10_3390_ph13110410
crossref_primary_10_3389_fnut_2020_582314
crossref_primary_10_1097_MBP_0000000000000450
crossref_primary_10_1007_s11695_015_1722_7
crossref_primary_10_1136_gutjnl_2015_310572
crossref_primary_10_1530_EC_18_0234
crossref_primary_10_1111_dom_15631
crossref_primary_10_3390_nu11081717
crossref_primary_10_1111_dom_13633
crossref_primary_10_1111_apha_12604
crossref_primary_10_2337_dc16_2391
crossref_primary_10_3390_nu17030479
crossref_primary_10_1016_j_diabres_2016_12_011
crossref_primary_10_1530_EJE_16_0507
crossref_primary_10_1161_HYPERTENSIONAHA_117_10740
crossref_primary_10_2337_dc16_0351
Cites_doi 10.7326/0003-4819-122-4-199502150-00009
10.1111/j.1532-5415.1997.tb05965.x
10.1210/jc.2009-1503
10.1042/cs0950719
10.1210/er.2011-1052
10.1007/s12325-010-0110-x
10.1038/nm.3128
10.1172/JCI0215595
10.1210/jc.2011-2583
10.1152/ajpregu.00732.2004
10.1053/ejvs.2001.1313
10.1373/clinchem.2005.057638
10.2337/db10-0474
10.1152/ajpheart.00930.2009
10.1152/ajpregu.00464.2011
10.1152/ajpregu.00235.2010
10.1016/j.regpep.2008.07.003
10.1111/j.1475-097X.1991.tb00459.x
10.1136/bmj.285.6346.916
10.1111/j.1532-5415.1994.tb06582.x
10.1152/ajpendo.00373.2007
10.1111/j.1532-5415.2005.53415.x
10.1016/S0167-0115(03)00111-3
10.1016/j.jamda.2014.01.011
10.1152/ajpregu.00215.2009
10.1016/S0016-5085(83)80232-7
10.1161/01.CIR.0000139339.85840.DD
10.1152/ajpregu.00153.2008
10.1517/13543780902766802
10.1093/gerona/glr086
10.1152/ajpregu.00378.2010
10.1007/s12325-013-0009-4
10.1042/cs0770085
10.1161/CIRCULATIONAHA.107.739938
10.1042/CS20110270
10.1016/j.amjmed.2005.05.019
10.1016/S0167-0115(96)00113-9
ContentType Journal Article
Copyright Copyright © 2014 by the Endocrine Society 2014
Copyright © 2014 by The Endocrine Society
Copyright © 2014 by the Endocrine Society
Copyright_xml – notice: Copyright © 2014 by the Endocrine Society 2014
– notice: Copyright © 2014 by The Endocrine Society
– notice: Copyright © 2014 by the Endocrine Society
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7T5
7TM
H94
K9.
7X8
DOI 10.1210/jc.2014-2475
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Immunology Abstracts
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Calcium & Calcified Tissue Abstracts
Nucleic Acids Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
AIDS and Cancer Research Abstracts


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1945-7197
EndPage E2634
ExternalDocumentID 25210879
10_1210_jc_2014_2475
00004678-201412000-00073
10.1210/jc.2014-2475
Genre Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-~X
.55
.XZ
08P
0R~
18M
1TH
29K
2WC
34G
354
39C
4.4
48X
53G
5GY
5RS
5YH
8F7
AABZA
AACZT
AAIMJ
AAPQZ
AAPXW
AARHZ
AAUAY
AAVAP
AAWTL
ABBLC
ABDFA
ABEJV
ABGNP
ABJNI
ABLJU
ABMNT
ABNHQ
ABOCM
ABPMR
ABPPZ
ABPQP
ABPTD
ABQNK
ABVGC
ABWST
ABXVV
ACGFO
ACGFS
ACPRK
ACUTJ
ACYHN
ADBBV
ADGKP
ADGZP
ADHKW
ADQBN
ADRTK
ADVEK
AELWJ
AEMDU
AENEX
AENZO
AETBJ
AEWNT
AFCHL
AFFZL
AFGWE
AFOFC
AFRAH
AFXAL
AGINJ
AGKRT
AGQXC
AGUTN
AHMBA
AHMMS
AJEEA
ALMA_UNASSIGNED_HOLDINGS
APIBT
ARIXL
ASPBG
ATGXG
AVWKF
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BSWAC
BTRTY
C45
CDBKE
CS3
D-I
DAKXR
DIK
E3Z
EBS
EJD
EMOBN
ENERS
F5P
FECEO
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
HZ~
H~9
KBUDW
KOP
KQ8
KSI
KSN
L7B
M5~
MHKGH
MJL
N9A
NLBLG
NOMLY
NOYVH
NVLIB
O9-
OAUYM
OBH
OCB
ODMLO
OFXIZ
OGEVE
OHH
OJZSN
OK1
OPAEJ
OVD
OVIDX
P2P
P6G
REU
ROX
ROZ
TEORI
TJX
TLC
TR2
TWZ
VVN
W8F
WOQ
X7M
YBU
YFH
YHG
YOC
YSK
ZY1
~02
~H1
.GJ
3O-
7X7
88E
8FI
8FJ
AAJQQ
AAKAS
AAPGJ
AAQQT
AAUQX
AAWDT
AAYJJ
ABDPE
ABUWG
ABXZS
ACFRR
ACVCV
ACZBC
ADMTO
ADNBA
ADZCM
AEMQT
AEOTA
AERZD
AFFNX
AFFQV
AFKRA
AFYAG
AGMDO
AGORE
AHGBF
AI.
AJBYB
AJDVS
ALXQX
APJGH
AQDSO
AQKUS
AVNTJ
BENPR
BPHCQ
BVXVI
CCPQU
EIHJH
FEDTE
FYUFA
HMCUK
HVGLF
IAO
IHR
INH
ITC
J5H
M1P
MBLQV
N4W
NU-
OBFPC
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
TMA
UKHRP
VH1
WHG
X52
ZGI
ZXP
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
7QP
7T5
7TM
H94
K9.
7X8
ID FETCH-LOGICAL-c4623-7ba7e87f58fbb2fc7d9c0a6ad0579e63876e3f02087bce99f63e340a7c03be013
ISSN 0021-972X
1945-7197
IngestDate Fri Jul 11 03:23:23 EDT 2025
Mon Jun 30 12:41:17 EDT 2025
Mon Jul 21 05:37:07 EDT 2025
Thu Apr 24 23:09:29 EDT 2025
Tue Jul 01 01:10:34 EDT 2025
Fri May 16 03:43:27 EDT 2025
Fri Feb 07 10:35:39 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4623-7ba7e87f58fbb2fc7d9c0a6ad0579e63876e3f02087bce99f63e340a7c03be013
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
PMID 25210879
PQID 3164460237
PQPubID 2046206
ParticipantIDs proquest_miscellaneous_1634279185
proquest_journals_3164460237
pubmed_primary_25210879
crossref_citationtrail_10_1210_jc_2014_2475
crossref_primary_10_1210_jc_2014_2475
wolterskluwer_health_00004678-201412000-00073
oup_primary_10_1210_jc_2014-2475
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20141201
2014-December
2014-12-01
2014-Dec
PublicationDateYYYYMMDD 2014-12-01
PublicationDate_xml – month: 12
  year: 2014
  text: 20141201
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Washington
PublicationTitle The journal of clinical endocrinology and metabolism
PublicationTitleAlternate J Clin Endocrinol Metab
PublicationYear 2014
Publisher Oxford University Press
Copyright by The Endocrine Society
Publisher_xml – name: Oxford University Press
– name: Copyright by The Endocrine Society
References Basu (2019041115292766600_B27) 2007; 293
Deane (2019041115292766600_B40) 2010; 95
Kim (2019041115292766600_B38) 2013; 19
Nauck (2019041115292766600_B17) 2011; 60
Brandt (2019041115292766600_B37) 2006; 52
Gentilcore (2019041115292766600_B7) 2009; 297
Horowitz (2019041115292766600_B18) 2013; 30
Trahair (2019041115292766600_B32) 2012; 97
Flint (2019041115292766600_B12) 2011; 28
Heddle (2019041115292766600_B29) 1988; 255
Brener (2019041115292766600_B9) 1983; 85
Vanis (2019041115292766600_B34) 2011; 300
Trahair (2019041115292766600_B6) 2014; 15
Piha (2019041115292766600_B30) 1991; 11
Brennan (2019041115292766600_B36) 2005; 288
Yamamoto (2019041115292766600_B23) 2002; 110
Aronow (2019041115292766600_B2) 1994; 42
Vilsbøll (2019041115292766600_B14) 2003; 114
Edwards (2019041115292766600_B24) 1998; 95
Jansen (2019041115292766600_B1) 1995; 122
Aronow (2019041115292766600_B4) 1997; 45
Linnebjerg (2019041115292766600_B35) 2008; 151
Fisher (2019041115292766600_B5) 2005; 53
Vanis (2019041115292766600_B11) 2012; 302
Malone (2019041115292766600_B13) 2009; 18
Trahair (2019041115292766600_B10) 2012; 122
Gentilcore (2019041115292766600_B19) 2005; 118
Vanis (2019041115292766600_B8) 2010; 299
Ussher (2019041115292766600_B21) 2012; 33
Halbirk (2019041115292766600_B25) 2010; 298
Perko (2019041115292766600_B31) 2001; 21
Nauck (2019041115292766600_B15) 1997; 273
Willms (2019041115292766600_B16) 1996; 81
Ewing (2019041115292766600_B33) 1982; 285
Bharucha (2019041115292766600_B26) 2008; 295
Barragán (2019041115292766600_B22) 1996; 67
Ban (2019041115292766600_B28) 2008; 117
Gentilcore (2019041115292766600_B20) 2011; 66
Nikolaidis (2019041115292766600_B39) 2004; 110
Mathias (2019041115292766600_B3) 1989; 77
References_xml – volume: 122
  start-page: 286
  year: 1995
  ident: 2019041115292766600_B1
  article-title: Postprandial hypotension: Epidemiology, pathophysiology, and clinical management
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-122-4-199502150-00009
– volume: 45
  start-page: 1051
  year: 1997
  ident: 2019041115292766600_B4
  article-title: Association of postprandial hypotension with incidence of falls, syncope, coronary events, stroke, and total mortality at 29-month follow-up in 499 older nursing home residents
  publication-title: J Am Geriatr Soc
  doi: 10.1111/j.1532-5415.1997.tb05965.x
– volume: 95
  start-page: 215
  year: 2010
  ident: 2019041115292766600_B40
  article-title: Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2009-1503
– volume: 95
  start-page: 719
  year: 1998
  ident: 2019041115292766600_B24
  article-title: Subcutaneous glucagon-like peptide-1 (7–36) amide is insulinotropic and can cause hypoglycaemia in fasted healthy subjects
  publication-title: Clin Sci (Lond)
  doi: 10.1042/cs0950719
– volume: 33
  start-page: 187
  year: 2012
  ident: 2019041115292766600_B21
  article-title: Cardiovascular biology of the incretin system
  publication-title: Endocr Rev
  doi: 10.1210/er.2011-1052
– volume: 28
  start-page: 213
  year: 2011
  ident: 2019041115292766600_B12
  article-title: The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients
  publication-title: Adv Ther
  doi: 10.1007/s12325-010-0110-x
– volume: 19
  start-page: 567
  year: 2013
  ident: 2019041115292766600_B38
  article-title: GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure
  publication-title: Nat Med
  doi: 10.1038/nm.3128
– volume: 110
  start-page: 43
  year: 2002
  ident: 2019041115292766600_B23
  article-title: Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons
  publication-title: J Clin Invest
  doi: 10.1172/JCI0215595
– volume: 97
  start-page: 844
  year: 2012
  ident: 2019041115292766600_B32
  article-title: Comparative effects of variations in duodenal glucose load on glycemic, insulinemic, and incretin responses in healthy young and older subjects
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2011-2583
– volume: 288
  start-page: R1477
  year: 2005
  ident: 2019041115292766600_B36
  article-title: Evaluation of interactions between CCK and GLP-1 in their effects on appetite, energy intake, and antropyloroduodenal motility in healthy men
  publication-title: Am J Physiol Regul Integr Comp Physiol
  doi: 10.1152/ajpregu.00732.2004
– volume: 21
  start-page: 106
  year: 2001
  ident: 2019041115292766600_B31
  article-title: Duplex ultrasound for assessment of superior mesenteric artery blood flow
  publication-title: Eur J Vasc Endovasc Surg
  doi: 10.1053/ejvs.2001.1313
– volume: 52
  start-page: 82
  year: 2006
  ident: 2019041115292766600_B37
  article-title: Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2005.057638
– volume: 60
  start-page: 1561
  year: 2011
  ident: 2019041115292766600_B17
  article-title: Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans
  publication-title: Diabetes
  doi: 10.2337/db10-0474
– volume: 298
  start-page: H1096
  year: 2010
  ident: 2019041115292766600_B25
  article-title: Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.00930.2009
– volume: 302
  start-page: R391
  year: 2012
  ident: 2019041115292766600_B11
  article-title: Effects of variations in intragastric volume on blood pressure and splanchnic blood flow during intraduodenal glucose infusion in healthy older subjects
  publication-title: Am J Physiol Regul Integr Comp Physiol
  doi: 10.1152/ajpregu.00464.2011
– volume: 299
  start-page: R960
  year: 2010
  ident: 2019041115292766600_B8
  article-title: Effects of gastric distension on blood pressure and superior mesenteric artery blood flow responses to intraduodenal glucose in healthy older subjects
  publication-title: Am J Physiol Regul Integr Comp Physiol
  doi: 10.1152/ajpregu.00235.2010
– volume: 273
  start-page: E981
  year: 1997
  ident: 2019041115292766600_B15
  article-title: Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans
  publication-title: Am J Physiol
– volume: 151
  start-page: 123
  year: 2008
  ident: 2019041115292766600_B35
  article-title: Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes
  publication-title: Regul Pept
  doi: 10.1016/j.regpep.2008.07.003
– volume: 11
  start-page: 277
  year: 1991
  ident: 2019041115292766600_B30
  article-title: Cardiovascular autonomic reflex tests: Normal responses and age-related reference values
  publication-title: Clin Physiol
  doi: 10.1111/j.1475-097X.1991.tb00459.x
– volume: 81
  start-page: 327
  year: 1996
  ident: 2019041115292766600_B16
  article-title: Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: Effects of exogenous glucagon-like peptide-1 (GLP-1)-(7–36) amide in type 2 (noninsulin-dependent) diabetic patients
  publication-title: J Clin Endocrinol Metab
– volume: 285
  start-page: 916
  year: 1982
  ident: 2019041115292766600_B33
  article-title: Diagnosis and management of diabetic autonomic neuropathy
  publication-title: Br Med J (Clin Res Ed)
  doi: 10.1136/bmj.285.6346.916
– volume: 42
  start-page: 930
  year: 1994
  ident: 2019041115292766600_B2
  article-title: Postprandial hypotension in 499 elderly persons in a long-term health care facility
  publication-title: J Am Geriatr Soc
  doi: 10.1111/j.1532-5415.1994.tb06582.x
– volume: 293
  start-page: E1289
  year: 2007
  ident: 2019041115292766600_B27
  article-title: Beneficial effects of GLP-1 on endothelial function in humans: Dampening by glyburide but not by glimepiride
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00373.2007
– volume: 53
  start-page: 1313
  year: 2005
  ident: 2019041115292766600_B5
  article-title: Postprandial hypotension predicts all-cause mortality in older, low-level care residents
  publication-title: J Am Geriatr Soc
  doi: 10.1111/j.1532-5415.2005.53415.x
– volume: 114
  start-page: 115
  year: 2003
  ident: 2019041115292766600_B14
  article-title: Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects
  publication-title: Regul Pept
  doi: 10.1016/S0167-0115(03)00111-3
– volume: 15
  start-page: 394
  year: 2014
  ident: 2019041115292766600_B6
  article-title: Postprandial Hypotension: A Systematic Review
  publication-title: J Am Med Dir Assoc
  doi: 10.1016/j.jamda.2014.01.011
– volume: 297
  start-page: R716
  year: 2009
  ident: 2019041115292766600_B7
  article-title: Comparative effects of oral and intraduodenal glucose on blood pressure, heart rate, and splanchnic blood flow in healthy older subjects
  publication-title: Am J Physiol Regul Integr Comp Physiol
  doi: 10.1152/ajpregu.00215.2009
– volume: 85
  start-page: 76
  year: 1983
  ident: 2019041115292766600_B9
  article-title: Regulation of the gastric emptying of glucose
  publication-title: Gastroenterology
  doi: 10.1016/S0016-5085(83)80232-7
– volume: 110
  start-page: 955
  year: 2004
  ident: 2019041115292766600_B39
  article-title: Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000139339.85840.DD
– volume: 295
  start-page: R874
  year: 2008
  ident: 2019041115292766600_B26
  article-title: Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans
  publication-title: Am J Physiol Regul Integr Comp Physiol
  doi: 10.1152/ajpregu.00153.2008
– volume: 18
  start-page: 359
  year: 2009
  ident: 2019041115292766600_B13
  article-title: Exenatide once weekly for the treatment of type 2 diabetes
  publication-title: Expert Opin Investig Drugs
  doi: 10.1517/13543780902766802
– volume: 66
  start-page: 917
  year: 2011
  ident: 2019041115292766600_B20
  article-title: The alpha ([alpha])-glucosidase inhibitor, acarbose, attenuates the blood pressure and splanchnic blood flow responses to intraduodenal sucrose in older adults
  publication-title: J Gerontol A Biol Sci Med Sci
  doi: 10.1093/gerona/glr086
– volume: 300
  start-page: R1524
  year: 2011
  ident: 2019041115292766600_B34
  article-title: Effects of small intestinal glucose load on blood pressure, splanchnic blood flow, glycemia, and GLP-1 release in healthy older subjects
  publication-title: Am J Physiol Regul Integr Comp Physiol
  doi: 10.1152/ajpregu.00378.2010
– volume: 30
  start-page: 81
  year: 2013
  ident: 2019041115292766600_B18
  article-title: Mechanisms and clinical efficacy of lixisenatide for the management of type 2 diabetes
  publication-title: Adv Ther
  doi: 10.1007/s12325-013-0009-4
– volume: 77
  start-page: 85
  year: 1989
  ident: 2019041115292766600_B3
  article-title: Differential blood pressure and hormonal effects after glucose and xylose ingestion in chronic autonomic failure
  publication-title: Clin Sci (Lond)
  doi: 10.1042/cs0770085
– volume: 255
  start-page: G490
  year: 1988
  ident: 2019041115292766600_B29
  article-title: Topography and measurement of pyloric pressure waves and tone in humans
  publication-title: Am J Physiol
– volume: 117
  start-page: 2340
  year: 2008
  ident: 2019041115292766600_B28
  article-title: Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.107.739938
– volume: 122
  start-page: 271
  year: 2012
  ident: 2019041115292766600_B10
  article-title: Effects of variations in duodenal glucose load on blood pressure, heart rate, superior mesenteric artery blood flow and plasma noradrenaline in healthy young and older subjects
  publication-title: Clin Sci (Lond)
  doi: 10.1042/CS20110270
– volume: 118
  start-page: 1289
  year: 2005
  ident: 2019041115292766600_B19
  article-title: Acarbose attenuates the hypotensive response to sucrose and slows gastric emptying in the elderly
  publication-title: Am J Med
  doi: 10.1016/j.amjmed.2005.05.019
– volume: 67
  start-page: 63
  year: 1996
  ident: 2019041115292766600_B22
  article-title: Interactions of exendin- (9–39) with the effects of glucagon-like peptide-1-(7–36) amide and of exendin-4 on arterial blood pressure and heart rate in rats
  publication-title: Regul Pept
  doi: 10.1016/S0167-0115(96)00113-9
SSID ssj0014453
Score 2.3176193
Snippet Context:Studies relating to the cardiovascular effects of glucagon-like peptide-1 (GLP-1) and its agonists, which slow gastric emptying, have not discriminated...
CONTEXT:Studies relating to the cardiovascular effects of glucagon-like peptide-1 (GLP-1) and its agonists, which slow gastric emptying, have not discriminated...
Studies relating to the cardiovascular effects of glucagon-like peptide-1 (GLP-1) and its agonists, which slow gastric emptying, have not discriminated between...
SourceID proquest
pubmed
crossref
wolterskluwer
oup
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage E2628
SubjectTerms Aged
Autonomic Nervous System - drug effects
Blood flow
Blood Glucose - metabolism
Blood pressure
Blood Pressure - drug effects
Cardiovascular system
Clinical trials
Double-Blind Method
Duodenum - metabolism
Fasting
Female
Gastric emptying
Glucagon
Glucagon-like peptide 1
Glucagon-Like Peptide 1 - pharmacology
Glucose
Glucose - administration & dosage
Glucose - pharmacology
Heart rate
Heart Rate - drug effects
Humans
Insulin - blood
Intubation, Gastrointestinal
Male
Mesenteric Arteries - drug effects
Peptides
Splanchnic Circulation - drug effects
Title Effects of Exogenous Glucagon-Like Peptide-1 on the Blood Pressure, Heart Rate, Mesenteric Blood Flow, and Glycemic Responses to Intraduodenal Glucose in Healthy Older Subjects
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00004678-201412000-00073
https://www.ncbi.nlm.nih.gov/pubmed/25210879
https://www.proquest.com/docview/3164460237
https://www.proquest.com/docview/1634279185
Volume 99
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtNAEF21RUIghIBSCBS0SPCUbBVf4o0fKeRSIICqVOqb5d1sqpBgo8ShlK_iE5nZi2NDKxVeosRZx3bmeHZmfc4MIS95Cg7ACzjjUVswrEbIUi_kLAWXKNpKyFA3mxh9jIYn4bvTzunW9m6FtbQuxIH8eamu5H-sCtvArqiS_QfLlj8KG-A92BdewcLwei0b9zZkjN6P3JZbHWAfs7M8Yx9mc9X8jKyViWKefSrQPESmulUFmvXnIYC9aB6nplHeSMuRNMHeDO0vzOMfXGEfLC6kZtMfG2qtqQ9xhAvEk3UOLgwMPrAkeF1EC8llF81P2AocfRQu-qyq8TCitFK8otRpqmySgz_LNhWivqoC8LpwFQ9xsQFF3rOlU3drFzU4KHGaL_Pzme5WW9MGaG-7Xs2Nux0vL86-l9juq1m2UOwQOQrFpvSCox7YxREvrBBNnFjBYzHXHdthujM-Pg47jHuGFuwmAdOlyYHdr7j0nh9Z-bpyn83y61-TD2TPOPlgYUw4Ez80LWHqNb7_mHtLRiTmYrB_8kUmuHeCe2-TGz4kP9iX4-3R-_LZWBja2qr20qycA7VY1WPXAq2aeLOSQ90md85zpGWs5lqVUYmtxvfIXZsU0dcG4ffJlsoekJsjS_vYJb8s0Gk-pSXQaQ3otAQ6zTMKQKcavdQBvUU1zCnCvEU3ILfDEOQtCjijDuK0hDgtclqDOLUQp7OMWohTDXHqIP6QnPR74zdDZluNMBlCAsC4SLnq8mmnOxXCn0o-iWU7jdIJarUVzFE8UsEUG9pyIVUcT6NABWE75bIdCAVp1B7ZyfJMPSa0K2IBcXHajmQUSl8K7ndlV4gueD4F6U2DNJ1dEmnr8GM7mEVyGQYa5FU5-pupP3PFOAomvmoIM0P2nf0Te2evksCDhCiCwJ03yIvya5hi8LlhmikwZwIpW-jzGCL7BnlkcFMeyIfwH_6UuEFYDUiJkXEneg0CAmKGp-G5OhY8eHLN63pKbm3u632yUyzX6hmkAYV4ru-K37r8Btc
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+Exogenous+Glucagon-Like+Peptide-1+on+the+Blood+Pressure%2C+Heart+Rate%2C+Mesenteric+Blood+Flow%2C+and+Glycemic+Responses+to+Intraduodenal+Glucose+in+Healthy+Older+Subjects&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Trahair%2C+Laurence+G.&rft.au=Horowitz%2C+Michael&rft.au=Hausken%2C+Trygve&rft.au=Feinle-Bisset%2C+Christine&rft.date=2014-12-01&rft.issn=0021-972X&rft.eissn=1945-7197&rft.volume=99&rft.issue=12&rft.spage=E2628&rft.epage=E2634&rft_id=info:doi/10.1210%2Fjc.2014-2475&rft.externalDBID=n%2Fa&rft.externalDocID=10_1210_jc_2014_2475
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon